Buckingham Capital Management Inc. Sells 5,476 Shares of Danaher Co. (NYSE:DHR)

Buckingham Capital Management Inc. reduced its position in Danaher Co. (NYSE:DHR - Free Report) by 77.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,570 shares of the conglomerate's stock after selling 5,476 shares during the period. Buckingham Capital Management Inc.'s holdings in Danaher were worth $436,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Weil Company Inc. increased its stake in Danaher by 33.8% in the 3rd quarter. Weil Company Inc. now owns 1,445 shares of the conglomerate's stock valued at $402,000 after buying an additional 365 shares during the period. Catalytic Wealth RIA LLC lifted its position in shares of Danaher by 54.3% during the 3rd quarter. Catalytic Wealth RIA LLC now owns 2,051 shares of the conglomerate's stock worth $570,000 after purchasing an additional 722 shares during the last quarter. Patten & Patten Inc. TN acquired a new position in shares of Danaher during the third quarter worth approximately $203,000. Kennebec Savings Bank acquired a new position in Danaher during the 3rd quarter valued at $819,000. Finally, Ashton Thomas Securities LLC bought a new stake in shares of Danaher in the third quarter valued at about $222,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Evercore ISI boosted their price objective on Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a research report on Tuesday, October 1st. Wolfe Research raised shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price on the stock in a research note on Thursday, October 31st. The Goldman Sachs Group raised their price target on shares of Danaher from $225.00 to $250.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 24th. Robert W. Baird lowered their price objective on Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 23rd. Finally, Wells Fargo & Company began coverage on Danaher in a report on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 target price for the company. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and a consensus target price of $287.16.

Danaher Price Performance

Shares of Danaher stock traded down $2.14 during midday trading on Monday, reaching $243.25. The company had a trading volume of 3,291,950 shares, compared to its average volume of 2,747,027. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $264.89 and a 200 day simple moving average of $260.84. Danaher Co. has a 1-year low of $193.75 and a 1-year high of $281.70. The company has a market capitalization of $175.69 billion, a price-to-earnings ratio of 47.31, a price-to-earnings-growth ratio of 4.51 and a beta of 0.85.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period last year, the firm earned $2.02 EPS. As a group, equities research analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher's dividend payout ratio (DPR) is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.